News

PepGen Inc. Faces Class Action: Investor Counsel Alert

PepGen Inc. Faces Class Action: Investor Counsel Alert

Important Notice for PepGen Inc. Investors

If you are an investor in PepGen Inc. (NASDAQ: PEPG), it's essential to stay informed about the ongoing securities class action. The Rosen Law Firm is urging shareholders who purchased PepGen securities from March 7, 2024, through March 3, 2025, to take a proactive stance.

Deadline for Participation

The law firm has set a lead plaintiff deadline of August 8, 2025. By this date, potential claimants must register to be part of the class. Failing to act could mean missing out on any financial restitution if the case is successful.

What You Need to Know

Investors who bought PepGen shares during the specified Class Period may be eligible for compensation without incurring out-of-pocket expenses, thanks to a contingency fee arrangement. This arrangement secures legal representation without advance fees, ensuring that claimants can pursue their rights efficiently and effectively.

Steps to Join the Class Action

To participate in the PepGen class action lawsuit, you can contact the Rosen Law Firm at (866) 767-3653 or reach out via email. It's crucial to complete your registration before the deadline to ensure you're covered as a participant in the class.

Why Choose Rosen Law Firm?

The Rosen Law Firm stands out due to its impressive track record in securities litigation. The firm has achieved landmark settlements and consistently ranks among the top legal firms for securities class action recovery. It focuses on shareholder rights and works tirelessly on behalf of its clients.

Details of the Lawsuit

The lawsuit alleges that PepGen made misleading statements concerning the efficacy and safety of its product, PGN-ED051. The defendants allegedly misled investors about the CONNECT2 study's potential for FDA approval, suggesting that the clinical data was valid when, in fact, it was under scrutiny. When the truth about these statements surfaced, investors experienced significant financial losses.

Understanding Your Rights

It’s important to note that as of now, no class has been officially certified. Therefore, investors are encouraged to select their legal representation carefully. The choice of counsel is a critical one; having experienced representation will ensure that your rights are well protected as the case unfolds.

Stay Informed

Follow the Rosen Law Firm on various social media platforms like LinkedIn, Twitter, and Facebook for updates on the ongoing litigation and important developments affecting investors.

Contact Information

Laurence Rosen, Esq. and Phillip Kim, Esq. are available to discuss any questions or concerns related to the class action. Investors can reach the firm at The Rosen Law Firm, P.A., located at 275 Madison Avenue, 40th Floor, New York, NY 10016. Contact number: (212) 686-1060 or toll-free at (866) 767-3653. Email: case@rosenlegal.com.

Frequently Asked Questions

What is the class action against PepGen Inc. about?

The class action lawsuit addresses misleading statements made by PepGen regarding the effectiveness and safety of its products.

How can I join the class action?

Investors can join by contacting the Rosen Law Firm before the deadline of August 8, 2025.

Are there any costs involved in participating?

No, investors can participate without any upfront costs due to the contingency fee arrangement.

Why is it important to have qualified legal counsel?

Qualified legal counsel can significantly influence the case's outcome and ensure that your rights are effectively represented.

What should I do if I missed the deadline?

If you missed the deadline, you may still seek legal advice on your options for pursuing compensation individually.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sobi Q3 2026 Report Defies Economic Headwinds

Updated Category News Views 0

Resilience in a Tough Market In a world where every finance report often feels like a gloomy weather forecast, Swedish Orphan Biovitrum AB, or Sobi for short, has come out swinging. They just dropped their Q3 2026 financials, and it's a breath of fresh air in these turbulent economic times. Sobi, primarily dealing in rare diseases, posted an impressive 16% revenue jump....

Continue Reading
Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 141

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Globe Life Faces 8% Stock Dip Amidst Legal Scrutiny

Updated Category News Views 120

Trouble Brews for Globe Life Investors Brace yourselves, folks. Globe Life Inc. (NYSE: GL) has found itself slap-bang in the middle of a potentially messy legal quagmire. The $7 million in excess Medicare Supplement claims that popped up due to a snail-like processing delay by the Centers for Medicare & Medicaid Services (CMS) have sent investors scrambling. And oh boy,...

Continue Reading
FOX's Watters Hosts Town Hall with VP Vance

Updated Category News Views 265

What's Brewing Between Jesse Watters and JD Vance? Who would've thought Texas would be the stage for FOX's Jesse Watters and Vice President JD Vance to lock horns over the country's pressing issues? Set your sights on the Lone Star State this October 29th as Watters rolls out the red carpet for Vance during Jesse Watters Primetime. It's a pre-taped town hall meet-up,...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 40

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Turbo VPN Adds 42 Server Locations, Expands Reach

Updated Category News Views 79

Turbo VPN Stretches Its Legs Globally Alright, let's take a dive into what Turbo VPN's up to with their network expansion. They're not just beefing up their presence; they're doubling down with 42 new server locations and heightening their streaming backbone. This isn't just another small tweak; it’s a strategic push that puts them firmly in 105 countries. It’s like...

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 31

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
GrOwnValve's Personalized Valves Pass Safety Milestone

Updated Category News Views 102

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Continue Reading
Latham & Watkins Welcomes Privacy Sledgehammer Macko

Updated Category News Views 100

Privacy Enforcer Lands at Latham & Watkins With regulatory pressure turning up the heat, Latham & Watkins has roped in Michael Macko, a seasoned pro when it comes to privacy enforcement. To give you a peek into his credibility, Macko doesn't just have a foot in the door—he built the doorframe himself over at the California Privacy Protection Agency (CalPrivacy)....

Continue Reading
EQS Group's Climate Goals Get SBTi Validation

Updated Category News Views 90

EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...

Continue Reading

Top 5 Most Recently Viewed Articles

Sinch Observes Rise in RCS Messaging with iOS 18 Support

Updated Category News Views 99

Growing Interest in RCS Messaging Over 70% of Brands Predict RCS Will Become a Primary Customer Communication Channel Within Five Years. Sinch (Sinch AB (publ)) (XSTO: SINCH), a leader in Customer Communications Cloud solutions, has reported a significant uptick in interest for Rich Communication Services (RCS) and RCS Business Messaging (RBM). Their discussions with a...

Continue Reading
Nutriband Celebrates New Milestone with Patent Approval for Aversa™

Updated Category News Views 140

Nutriband's Patent Notice - A Step Forward for Aversa™ Technology Nutriband Inc. (NASDAQ:NTRB) recently achieved a major milestone in the realm of pharmaceutical innovation by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its Aversa™ abuse deterrent technology. This exciting development signals the impending issuance of...

Continue Reading
SEGG Media Unveils $300 Million Strategy for Web3 and Digital Assets

Updated Category News Views 152

SEGG Media's Bold Leap into the Future of Digital Assets Today marks a significant turning point for SEGG Media Corporation (NASDAQ: SEGG, LTRYW) as it unveils its ambitious Web3 and Digital Asset Strategy. With a planned investment of $300 million over the next two years, SEGG Media aims to revolutionize the landscape of sports and entertainment by introducing...

Continue Reading
LAVA Therapeutics Reaches Key Milestone in Tender Offer Process

Updated Category News Views 160

LAVA Therapeutics Makes Significant Announcement on Tender Offer Today, LAVA Therapeutics N.V. (Nasdaq: LVTX) revealed a pivotal moment in its tender offer, successfully meeting the minimum share tender condition established for its ongoing acquisition process. In a vibrant report from the Netherlands and Philadelphia, the company announced that an impressive 22,877,463...

Continue Reading
23andMe Strengthens Leadership with Three New Board Directors

Updated Category News Views 289

23andMe Enhances Board Composition with New Directors 23andMe Holding Co. (NASDAQ: ME), a pioneering company in human genetics and preventive health, has recently made significant changes to its Board of Directors. This move is aimed at fostering strategic growth as the company strives to maintain its leadership position in the healthcare market. Introduction of...

Continue Reading